{
    "Trade/Device Name(s)": [
        "ACCU-CHEK Performa Blood Glucose Monitoring System",
        "ACCU-CHEK Performa System",
        "ACCU-CHEK Performa Test Strip",
        "ACCU-CHEK Performa Meter"
    ],
    "Submitter Information": "Roche Diagnostic Corporation",
    "510(k) Number": "K133741",
    "Predicate Device Reference 510(k) Number(s)": [
        "K121679"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "LFR"
    ],
    "Summary Letter Date": "July 25, 2014",
    "Summary Letter Received Date": "July 29, 2014",
    "Submission Date": "August 26, 2014",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Venous whole blood",
        "Fresh capillary whole blood from fingertips"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "ACCU-CHEK Performa Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Amperometric detection",
        "Mut. Q-GDH enzymatic method"
    ],
    "Methodologies": [
        "Quantitative measurement"
    ],
    "Submission Type(s)": [
        "System",
        "Test Strip",
        "Meter"
    ],
    "Document Summary": "FDA 510(k) summary for ACCU-CHEK Performa Blood Glucose Monitoring System for quantitative measurement of glucose in whole blood using amperometric detection.",
    "Indications for Use Summary": "Intended for quantitative measurement of glucose in venous or fresh capillary whole blood from the fingertips; for multiple-patient use in professional healthcare settings to aid monitoring effectiveness of glucose control; not for diagnosis, screening, or neonatal use.",
    "fda_folder": "Clinical Chemistry"
}